Erratum to: GH modulates hepatic epidermal growth factor signaling in the mouse (Journal of Endocrinology 204: part 3 (299–309) DOI: 10.1677/JOE-09-0372);GH modulates hepatic epidermal growth factor signaling in the mouse

Journal of Endocrinology

Volumn 204, Issue 3, 2010, Pages 299-309

  González, Lorena ^a   Díaz, Ma Eugenia ^a   Miquet, Johanna G ^a   Sotelo, Ana I ^a   Fernández, Diego ^a   Dominici, Fernando P ^a   Bartke, Andrzej ^a,b   Turyn, Daniel ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH HORMONE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B BETA; PROTEIN TYROSINE PHOSPHATASE; STAT3 PROTEIN; STAT5 PROTEIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; FEMALE; GENE OVEREXPRESSION; HORMONE DETERMINATION; KNOCKOUT GENE; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 76649111069     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-09-0372e     Document Type: Erratum

References (57)

1. Anisimov VN 2001 Mutant and genetically modified mice as models for studying the relationship between aging and carcinogenesis. Mechanisms of Ageing and Development 122 1221-1255.
2. Barreca A, Voci A, Minuto F, de Marchis M, Cecchelli E, Fugassa E, Giordano G & Gallo G 1992 Effect of epidermal growth factor on insulin-like growth factor-I (IGF-I) and IGF-binding protein synthesis by adult rat hepatocytes. Molecular and Cellular Endocrinology 84 119-126.
3. Bartke A 2003 Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice Neuroendocrinology 78 210-216.
4. Batzer AG, Rotin D, Ureña JM, Skolnik EY & Schlessinger J 1994 Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Molecular and Cellular Biology 14 5192-5201.
5. Boeri Erba E, Bergatto E, Cabodi S, Silengo L, Tarone G, Defilippi P & Jensen ON 2005 Systematic analysis of the epidermal growth factor receptor by mass spectrometry reveals stimulation-dependent multisite phosphorylation. Molecular and Cellular Proteomics 4 1107-1121.
6. Boerner JL, Gibson MA, Fox EM, Posner ED, Parsons SJ, Silva CM & Shupnik MA 2005 Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells. Molecular Endocrinology 19 2660-2670.
7. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 248-254.
8. Brooks AJ, Wooh JW, Tunny KA & Waters MJ 2008 Growth hormone receptor; mechanism of action. International Journal of Biochemistry & Cell Biology 40 1984-1989.
9. Chen J, Yu W-M, Bunting KD & Qu C-K 2004 A negative role of SHP-2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survival. Oncogene 23 3659-3669.
10. Chong ZZ & Maiese K 2007 The src homology 2 domain tyrosine phosphatase SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histology and Histopathology 22 1251-1267.
11. Chughtai N, Schimchowitsch S, Lebrun J-J & Ali S 2002 Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the β-casein gene promoter in mammary cells. Journal of Biological Chemistry 277 31107-31114.
12. Coffer PJ & Kruijer W 1995 EGF receptor deletions define a region specifically mediating STAT transcription factor activation. Biochemical and Biophysical Research Communications 210 74-81.
13. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H et al. 1997 A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387 921-924.
14. González L, Miquet JG, Sotelo AI, Bartke A & Turyn D 2002 Cytokine-inducible SH2 protein up-regulation is associated with desensitization of GH signaling in GHRH-transgenic mice. Endocrinology 143 386-394.
15. Grunnet N, Peng X & Tygstrup N 1999 Growth factors and gene expression in cultured rat hepatocytes. Journal of Hepatology 31 117-122.
16. Hartmann H, Schmitz F, Christ B, Jungermann K & Creutzfeldt W 1990 Metabolic actions of insulin-like growth factor-I in cultured hepatocytes from adult rats. Hepatology 12 1139-1143.
17. Henson ES & Gibson SB 2006 Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cellular Signalling 18 2089-2097.
18. Huang Y, Kim SO, Jiang J & Frank SJ 2003 Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling. Journal of Biological Chemistry 278 18902-18913.
19. Huang Y, Chang Y,Wang X, Jiang J & Frank SJ 2004 Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells. Endocrinology 145 3297-3306.
20. Ikeno Y, Bronson RT, Hubbard GB, Lee S & Bartke A 2003 Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 58 291-296.
21. Ito Y, Takeda T, Sakon M, Tsujimoto M, Higashiyama S, Noda K, Miyoshi E, Monden M & Matsuura N 2001 Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. British Journal of Cancer 84 1377-1383.
22. Jansson JO, Ekberg S, Hoath SB, Beamer WG & Frohman LA 1988 Growth hormone enhances hepatic epidermal growth factor receptor concentration in mice. Journal of Clinical Investigation 82 1871-1876.
23. Jenkins PJ 2004 Acromegaly and cancer. Hormone Research 62 108-115.
24. Johansson S, Husman B, Norstedt G & Andersson G 1989 Growth hormone regulates the rodent hepatic epidermal growth factor receptor at a pretranslational level. Journal of Molecular Endocrinology 3 113-120.
25. Jorissen RN,Walker F, Pouliot N, Garrett TP,Ward CW & Burgess AW2003 Epidermal growth factor receptor: mechanisms of activation and signalling. Experimental Cell Research 284 31-53.
26. Kim SO, Houtman JC, Jiang J, Ruppert JM, Bertics PJ & Frank SJ 1999 Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts. Journal of Biological Chemistry 274 36015-36024.
27. Kimura M & Ogihara M 1998 Effects of insulin-like growth factor I and II on DNA synthesis and proliferation in primary cultures of adult rat hepatocytes. European Journal of Pharmacology 354 271-281.
28. Lanning NJ & Carter-Su C 2007 Recent advances in growth hormone signaling. Reviews in Endocrine & Metabolic Disorders 7 225-235.
29. McGrane MM, Yun JS, Moorman AF, Lamers WH, Hendrick GK, Arafah BM, Park EA, Wagner TE & Hanson RW 1990 Metabolic effects of developmental, tissue-, and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice. Journal of Biological Chemistry 265 22371-22379.
30. Miquet JG, Sotelo AI, Bartke A & Turyn D 2004 Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH. Endocrinology 145 2824-2832.
31. Miquet JG, Sotelo AI, Bartke A & Turyn D 2005 Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice. American Journal of Physiology. Endocrinology and Metabolism 289 E600-E607.
32. Miquet JG, González L, Matos MN, Hansen C, Louis A, Bartke A, Turyn D & Sotelo AI 2008 Transgenic mice overexpressing GH exhibit hepatic upregulation of GH-signaling mediators involved in cell proliferation. Journal of Endocrinology 198 317-330.
33. Normanno N, Bianco C, De luca A & Salomon DS 2001 The role of EGF-related peptides in tumor growth. Frontiers in Bioscience 6 d685-d707.
34. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F & Salomon DS 2006 Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366 2-16.
35. Orian JM, Tamakoshi K, Mackay IR & Brandon MR 1990 New murine model for hepatocellular carcinoma: transgenic mice expressing metallothionein-ovine growth hormone fusion gene. Journal of the National Cancer Institute 82 393-398.
36. Pollak M, Blouin MJ, Zhang JC & Kopchick JJ 2001 Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist. British Journal of Cancer 85 428-430.
37. Quesnelle KM, Boehm AL & Grandis JR 2007 STAT-mediated EGFR signaling in cancer. Journal of Cellular Biochemistry 102 311-319 (Review).
38. Raccurt M, Lobie PE, Moudilou E, Garcia-Caballero T, Frappart L, Morel G &Mertani HC 2002 High stromal and epithelial human gh gene expression is associated with proliferative disorders of the mammary gland. Journal of Endocrinology 175 307-318.
39. Santos A, Yusta B, Fernandez-Moreno MD & Blazquez E 1994 Expression of insulin-like growth factor-I (IGF-I) receptor gene in rat brain and liver during development and in regenerating adult rat liver. Molecular and Cellular Endocrinology 101 85-93.
40. Siegel G & Tomer Y 2005 Is there an association between acromegaly and thyroid carcinoma? A critical review of the literature Endocrine Research 31 51-58.
41. Snibson KJ 2002 Hepatocellular kinetics and the expression of growth hormone (GH) in the livers and liver tumours of GH-transgenic mice. Tissue & Cell 34 88-97.
42. Stofega MR, Herrington J, Billestrup N & Carter Su C 2000 Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosil phophorylation of GH receptor, JAK2 and STAT5B. Molecular Endocrinology 14 1338-1350.
43. Styles JA, Kelly MD, Pritchard NR & Foster JR 1990 Effects produced by the non-genotoxic hepatocarcinogen methylclofenapate in dwarf mice: peroxisome induction uncoupled from DNA synthesis and nuclearity changes. Carcinogenesis 3 387-391.
44. Swanson SM & Unterman TG 2002 The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis. Carcinogenesis 23 977-982.
45. Wanke R, Hermanns W, Folger S, Wolf E & Brem G 1991 Accelerated growth and visceral lesions in transgenic mice expressing foreign genes of the growth hormone family: an overview. Pediatric Nephrology 5 513-521.
46. Waters MJ, Hoang HN, Fairlie DP, Pelekanos RA & Brown RJ 2006 New insights into growth hormone action. Journal of Molecular Endocrinology 36 1-7.
47. Webb SM, Casanueva F &Wass JA 2002 Oncological complications of excess GH in acromegaly. Pituitary 5 21-25.
48. Woelfle J & Rotwein P 2004 In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. American Journal of Physiology. Endocrinology and Metabolism 286 E393-E401.
49. Wu SL, Kim J, Bandle RW, Liotta L, Petricoin E & Karger BL 2006 Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using Extended Range Proteomic Analysis (ERPA). Molecular and Cellular Proteomics 9 1610-1627.
50. Yamashita H, Iwase H, Toyama T & Fujii Y 2003 Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells. Oncogene 22 1638-1652.
51. Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M, Honjo M, Takahashi M, Takahashi T, Hirai H et al. 1997 Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390 91-96.
52. Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M, Honjo M, Takahashi M, Takahashi T, Hirai H et al. 1998 Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression. Endocrine Journal 45 S27-S31.
53. Yamauchi T, Yamauchi N, Ueki K, Sugiyama T, Waki H, Miki H, Tobe K, Matsuda S, Tsushima T, Yamamoto T et al. 2000 Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer. Journal of Biological Chemistry 275 33937-33944.
54. Yu H & Jove R 2004 The STATs of cancer - new molecular targets come of age. Nature Reviews. Cancer 4 97-105.
55. Zhang T, Ma J & Cao X 2003 Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling. Biochemical Journal 376 457-464.
56. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K,Wagner TE et al. 1997 A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). PNAS 94 13215-13220.
57. Zhu T, Goh EL, Graichen R, Ling L & Lobie PE 2001 Signal transduction via the growth hormone receptor. Cellular Signalling 13 599-616.